Mass tort settlement news this week brought several high-profile developments across pharmaceutical, environmental, and consumer product litigation. From a landmark $885 million antitrust verdict against Takeda to social media companies settling school district lawsuits before trial, the week of May 18, 2026 delivered major updates for plaintiffs and attorneys alike. Meanwhile, the Depo-Provera MDL surpassed 6,000 filings as courts prepare for critical expert hearings later this month. Here is your weekly roundup of the most important mass tort settlement news and what it means for affected individuals.
Pharmaceutical Mass Tort Settlement News This Week
The biggest pharmaceutical mass tort settlement news came from a Boston federal courtroom. A jury hit Takeda Pharmaceuticals with an $884.9 million verdict for pay-for-delay antitrust violations involving its constipation drug Amitiza. The jury found Takeda paid Par Pharmaceutical $210 million to delay a generic version until 2021. Under federal antitrust trebling rules, the award could swell to $2.47 billion. This marks the first time a federal jury has held a drugmaker liable in a pay-for-delay case. Takeda has announced plans to appeal.
In addition, the Depo-Provera brain tumor litigation continued its rapid growth. Filings now exceed 6,000 cases, with the federal MDL seeing a 47.7% increase in a single month earlier this year. Women allege that Pfizer’s injectable birth control caused meningioma brain tumors. Canada and the EU had label warnings for years before the U.S. label was updated in December 2025. Rule 702 expert hearings are scheduled for May 26–28. The general causation Daubert hearing follows on June 24–25. The first bellwether trial is expected in December 2026.
Meanwhile, Zantac litigation suffered a setback in Delaware. Superior Court Judge Francis Jones dismissed cancer claims against GSK. He ruled plaintiffs failed to produce legitimate evidence linking ranitidine to cancer. However, courts in California and Illinois have allowed similar evidence to proceed. The litigation is far from over. For example, opioid settlement funds continued reaching communities this week. North Carolina Governor Josh Stein visited a Charlotte rehabilitation center to highlight how settlement distributions are supporting recovery programs statewide.
Medical Device Lawsuit Developments
Mass tort settlement news in the medical device space centered on two major MDLs this week. The hernia mesh litigation now includes 26,283 pending cases across multiple MDLs. Becton Dickinson reached a global agreement to resolve tens of thousands of Bard hernia mesh claims using a points-based allocation system. Payments are tied to injury severity. The first Covidien bellwether trial is rescheduled for July 2026. As a result, affected patients should consult a licensed attorney to understand how the allocation framework may apply to their case.
In addition, the DOJ announced that a New Jersey medical device manufacturer admitted to selling contaminated ultrasound gel. A federal court ordered a permanent injunction against the company on May 11. This case underscores the importance of FDA compliance in the medical device industry. Patients who experienced adverse reactions from contaminated medical products may qualify for potential recovery through individual claims. Those concerned about medical device injuries can review active MDL cases to find relevant litigation.
Environmental Contamination Case Updates
Environmental mass tort settlement news was dominated by PFAS developments this week. A new motion asked the JPML to centralize firefighter turnout gear lawsuits into a new MDL. Five class actions allege PFAS chemicals in protective gear caused cancer in firefighters. The proposed MDL would be housed in the District of Minnesota. A study of Michigan firefighters found PFAS in most participants’ blood samples.
However, declining levels offered cautious optimism. San Francisco’s ban on PFAS in turnout gear takes full effect June 30. Meanwhile, the EPA faced criticism for proposing to weaken national drinking water standards for PFAS. Earthjustice and Waterkeeper Alliance warned the rollback threatens public health. Maine awarded $3 million for research to mitigate PFAS impact on farms.
The AFFF water contamination MDL now includes 15,232 active lawsuits. Prior settlements from 3M, DuPont, and others total over $12 billion. EPA data shows an additional 7 million Americans affected by PFAS-contaminated drinking water. Personal injury bellwether trials could come later in 2026.
📨 Get Free Mass Tort Guides Alerts
Free · No spam · Unsubscribe anytime
Camp Lejeune mass tort settlement news showed incremental progress. The DOJ has paid $421 million through the Elective Option program since January 2025. Individual payouts range from $100,000 to $550,000. However, fewer than 2,400 of over 400,000 claims have been resolved. Twenty-four cases are heading to trial in 2026 in the Eastern District of North Carolina.
The Roundup litigation awaits a Supreme Court decision expected by late June. Bayer’s proposed $7.25 billion class settlement has a June 4 opt-out deadline. One federal judge called the deal structure “filthy.” Over 65,000 claims remain unresolved.
Consumer Product Litigation News
Consumer product mass tort settlement news featured a breakthrough in social media litigation. YouTube, TikTok, and Snap settled with Kentucky’s Breathitt County School District just before the first major trial. The district had sought over $60 million for student mental health programs. Settlement terms were not disclosed. Only Meta Platforms remains as a defendant for the June 12 trial in Oakland. This is a test case among 1,200 similar school district lawsuits. Bloomberg Intelligence estimates collective theoretical liability at nearly $400 billion.
The hair relaxer MDL now includes 11,526 pending lawsuits. Judge Mary Rowland personally selected all 10 bellwether cases after scrapping the party-driven process. First-wave discovery is largely complete. Plaintiffs have requested approval of medical monitoring classes in seven states plus D.C. No settlements have been announced. First bellwether trials are not expected until 2027. For a broader understanding of how these cases move through the courts, visit our guide on what is a mass tort.
Research published this week estimated that social media’s damage to teen mental health may cost £3 billion annually in the UK alone. These findings could bolster claims in pending U.S. litigation. Affected school districts considering legal action can review state-specific tort reform rules that may impact their cases.
Key Deadlines and What to Watch
| Date | Event | Why It Matters |
|---|---|---|
| May 26–28 | Depo-Provera Rule 702 Hearings | Expert testimony admissibility could shape the entire MDL |
| June 4 | Roundup Settlement Opt-Out Deadline | Last chance to exit the $7.25B class deal and pursue individual claims |
| June 12 | Social Media MDL Trial (Meta) | First school district case to reach a jury verdict |
| June 24–25 | Depo-Provera Daubert Hearing | General causation ruling will determine if cases proceed |
| Late June | Supreme Court Roundup Decision | Could eliminate state-law failure-to-warn claims nationwide |
| July 2026 | Covidien Hernia Mesh Bellwether | First trial for this defendant group |
This week’s mass tort settlement news underscores how quickly the litigation landscape shifts. New verdicts, settlements, and regulatory changes can affect eligibility and potential recovery for thousands of claimants. If you believe you may be affected by any of these cases, take our eligibility quiz and consult a licensed attorney to evaluate your options. Check back next week for the latest mass tort settlement news updates.
Check If You May Qualify
Mass tort eligibility depends on your specific exposure, injuries, and the state where you live. A licensed mass tort attorney can evaluate your situation at no upfront cost — most work on contingency, meaning you pay nothing unless you recover compensation.
Official Sources & Resources
For verified mass tort and MDL information:
- JPML: jpml.uscourts.gov — official MDL statistics and transfer orders
- DOJ: justice.gov — settlement announcements and press releases
- FDA: fda.gov — drug recalls, warning letters, and safety alerts
- CDC: cdc.gov — health condition data and exposure guidelines
- EPA: epa.gov — environmental contamination data
- Cornell LII: law.cornell.edu — plain-English legal definitions
Content last reviewed May 2026. This is general educational information, not legal advice. If you notice outdated information, please contact us.
Related Guides
- All Active MDL Cases
- More in This Category
- Tort Reform by State — 50-State Comparison
- All 50 State Tort Reform Guides
- Mass Tort Explainers
- Demographic Guides
- Mass Tort Tips
- Illinois Tort Reform Guide
- Pennsylvania Tort Reform Guide
- Ohio Tort Reform Guide
Attorney Advertising. The information on this page is provided for general informational purposes only and does not constitute legal advice. No attorney-client relationship is created by accessing or using this content. Every case is unique, and results depend on the specific facts and circumstances involved. Past settlement amounts and case outcomes do not guarantee similar results in your case. If you believe you have a legal claim, you should consult with a licensed attorney in your jurisdiction who can evaluate your specific situation.